Access to anti-retroviral drugs, male in Congo
Congo: Access to anti-retroviral drugs, male was 40.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Congo, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Congo stood at 40.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 17.6% on the previous year and up 110.5% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Congo peaked at 40.0% in 2024 and was at its lowest, 0.0%, in 2000.
Congo ranks 131st of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Congo, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 4.0% | — |
| 2006 | 5.0% | +25.0% |
| 2007 | 7.0% | +40.0% |
| 2008 | 15.0% | +114.3% |
| 2009 | 18.0% | +20.0% |
| 2010 | 22.0% | +22.2% |
| 2011 | 16.0% | -27.3% |
| 2012 | 18.0% | +12.5% |
| 2013 | 20.0% | +11.1% |
| 2014 | 19.0% | -5.0% |
| 2015 | 20.0% | +5.3% |
| 2016 | 21.0% | +5.0% |
| 2017 | 22.0% | +4.8% |
| 2018 | 23.0% | +4.5% |
| 2019 | 23.0% | +0.0% |
| 2020 | 24.0% | +4.3% |
| 2021 | 30.0% | +25.0% |
| 2022 | 31.0% | +3.3% |
| 2023 | 34.0% | +9.7% |
| 2024 | 40.0% | +17.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.9% | 0.0% | 18.0% | 10 |
| 2010s | 20.4% | 16.0% | 23.0% | 10 |
| 2020s | 31.8% | 24.0% | 40.0% | 5 |
Countries ranked near Congo
More gender data for Congo
- Child population (UN estimates and projections) 2,740 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.35 % change on previous year (2030)
- Population 4,543 (2030)
- Working-age population (UN estimates and projections) 4,543 (2030)
- Age population, age 00, female, interpolated 93,771 (2025)
- Age population, age 00, male, interpolated 95,629 (2025)
- Age population, age 01, female, interpolated 91,657 (2025)
- Age population, age 01, male, interpolated 93,441 (2025)
- Age population, age 02, female, interpolated 89,756 (2025)
- Age population, age 02, male, interpolated 91,560 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Congo?
- Access to anti-retroviral drugs, male in Congo was 40.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Congo?
- The highest recorded value was 40.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Congo?
- The lowest recorded value was 0.0% in 2000.
- How does Congo rank for access to anti-retroviral drugs, male?
- Congo ranks 131st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Congo?
- Over the last ten years it is up 110.5%. The long-run trend across the full record is volatile.
- Where does this Congo data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.